AR051974A1 - Procedimiento para la preparacion de un antagonista del leucotrieno y variedad cristalina del mismo - Google Patents
Procedimiento para la preparacion de un antagonista del leucotrieno y variedad cristalina del mismoInfo
- Publication number
- AR051974A1 AR051974A1 ARP050104981A ARP050104981A AR051974A1 AR 051974 A1 AR051974 A1 AR 051974A1 AR P050104981 A ARP050104981 A AR P050104981A AR P050104981 A ARP050104981 A AR P050104981A AR 051974 A1 AR051974 A1 AR 051974A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- preparation
- formula
- leucotrene
- antigonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente se refiere al ácido libre de este compuesto en forma cristalina, que se obtiene, por primera vez, a través del procedimiento. Reivindicacion 1: Un procedimiento para la preparacion de un compuesto de formula (1), en la cual R representa H o Na, y dicho procedimiento consiste en: a) hacer reaccionar un compuesto de formula (2), con el ácido 1-(mercaptometil)-ciclopropanoacético de formula (3), en presencia de una base, b) acidificar la solucion obtenida para producir un compuesto de formula (4), c) y opcionalmente, transformar el compuesto obtenido en la etapa b) en un compuesto de formula (5).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2004/013598 WO2006058545A1 (en) | 2004-11-30 | 2004-11-30 | New process for the preparation of a leukotriene antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
AR051974A1 true AR051974A1 (es) | 2007-02-21 |
Family
ID=34959312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050104981A AR051974A1 (es) | 2004-11-30 | 2005-11-29 | Procedimiento para la preparacion de un antagonista del leucotrieno y variedad cristalina del mismo |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080214822A1 (es) |
EP (1) | EP1817289A1 (es) |
AR (1) | AR051974A1 (es) |
CA (1) | CA2589936A1 (es) |
IL (1) | IL183255A0 (es) |
WO (1) | WO2006058545A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007532686A (ja) | 2004-04-21 | 2007-11-15 | テバ ファーマシューティカル インダストリーズ リミティド | モンテルカストナトリウムを調製する方法 |
JP2008510840A (ja) | 2005-07-05 | 2008-04-10 | テバ ファーマシューティカル インダストリーズ リミティド | モンテルカストの精製 |
ES2403067T3 (es) | 2005-12-13 | 2013-05-13 | Msn Laboratories Limited | Un procedimiento mejorado para la preparación de montelukast y sus sales farmaceúticamente aceptables |
US7528254B2 (en) * | 2006-02-27 | 2009-05-05 | Chemagis Ltd. | Process for preparing montelukast and salts thereof |
US20090281323A1 (en) * | 2006-04-12 | 2009-11-12 | Glade Organics Private Limited | Process for the manufacture of montelukast sodium |
US20060223999A1 (en) * | 2006-05-10 | 2006-10-05 | Chemagis Ltd. | Process for preparing montelukast and precursors thereof |
WO2008001213A1 (en) * | 2006-06-26 | 2008-01-03 | Aurobindo Pharma Limited | An improved process for the preparation of leukotriene receptor antagonist (montelukast sodium) |
WO2008015703A2 (en) * | 2006-08-04 | 2008-02-07 | Matrix Laboratories Ltd | Process for the preparation of montelukast and its salts thereof |
EP1886997A1 (en) * | 2006-08-09 | 2008-02-13 | Esteve Quimica, S.A. | Process for the purification of montelukast |
US8115004B2 (en) | 2006-11-20 | 2012-02-14 | Msn Laboratories Limited | Process for pure montelukast sodium through pure intermediates as well as amine salts |
KR100774088B1 (ko) | 2006-12-14 | 2007-11-06 | 한미약품 주식회사 | 몬테루카스트의 제조방법 및 이에 사용되는 중간체 |
WO2008087628A1 (en) * | 2007-01-15 | 2008-07-24 | Chemagis Ltd. | Process for preparing montelukast sodium containing controlled levels of impurities |
CN101889081B (zh) | 2007-09-28 | 2014-06-18 | 科德克希思公司 | 酮还原酶多肽及其用途 |
KR100893756B1 (ko) * | 2009-01-14 | 2009-04-22 | 주식회사 메디켐코리아 | 몬테루카스트의 효율적 제조방법 |
WO2010148209A2 (en) * | 2009-06-19 | 2010-12-23 | Dr. Reddy's Laboratories Ltd. | Preparation of montelukast |
WO2011121091A1 (en) | 2010-03-31 | 2011-10-06 | Krka, D.D., Novo Mesto | Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein |
HUP1000425A2 (en) | 2010-08-11 | 2012-03-28 | Richter Gedeon Nyrt | Process for the production of montelukast sodium |
KR20140108627A (ko) * | 2011-07-26 | 2014-09-12 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 퀴놀린-, 퀸옥살린 또는 벤조티아졸계 시스테이닐 류코트리엔 길항물질 (ltc4) |
WO2014001860A1 (en) * | 2012-05-18 | 2014-01-03 | Laurus Labs Private Limited | Process for preparation of montelukast sodium |
CN105085391B (zh) * | 2015-06-10 | 2017-08-22 | 广东默泰同创医药科技有限公司 | 用作白三烯受体拮抗剂的环丙基不饱和喹啉化合物及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5565473A (en) * | 1990-10-12 | 1996-10-15 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
DK0480717T3 (da) * | 1990-10-12 | 1999-02-08 | Merck Frosst Canada Inc | Umættede hydroxyalkylquinolinsyrer som leukotrienantagonister |
TW416948B (en) * | 1993-12-28 | 2001-01-01 | Merck & Co Inc | Process for the preparation of leukotriene antagonists |
WO2003066598A1 (en) * | 2002-02-07 | 2003-08-14 | Dr. Reddy's Laboratories Ltd. | Novel anhydrous amorphous forms of montelukast sodium salt |
CA2528228C (en) * | 2003-06-06 | 2011-09-20 | Morepen Laboratories Limited | A method for the preparation of montelukast acid and sodium salt thereof in amorphous form |
ATE522507T1 (de) * | 2003-10-10 | 2011-09-15 | Synhton B V | Montelukast in fester phase |
-
2004
- 2004-11-30 US US11/791,896 patent/US20080214822A1/en not_active Abandoned
- 2004-11-30 CA CA002589936A patent/CA2589936A1/en not_active Abandoned
- 2004-11-30 EP EP04798127A patent/EP1817289A1/en not_active Withdrawn
- 2004-11-30 WO PCT/EP2004/013598 patent/WO2006058545A1/en active Application Filing
-
2005
- 2005-11-29 AR ARP050104981A patent/AR051974A1/es unknown
-
2007
- 2007-05-16 IL IL183255A patent/IL183255A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006058545A1 (en) | 2006-06-08 |
CA2589936A1 (en) | 2006-06-08 |
EP1817289A1 (en) | 2007-08-15 |
US20080214822A1 (en) | 2008-09-04 |
IL183255A0 (en) | 2007-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR051974A1 (es) | Procedimiento para la preparacion de un antagonista del leucotrieno y variedad cristalina del mismo | |
CY1118310T1 (el) | Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξυαμιδο-πυριδινο βενζοϊκων οξεων | |
AR066130A1 (es) | Formas cristalinas de saxagliptina y procesos para preparar las mismas | |
CR8640A (es) | Proceso para producir un compuesto de 5-hidroxi-4-tiometilpirazol | |
CY1110800T1 (el) | Μεθανοσουλφονικα αλατα αβιρατερονης-3-εστερων και ανακτηση αλατων αβιρατερονης-3-εστερων απο διαλυμα σε μεθυλο τριτ-βουτυλαιθερα | |
CO6140036A2 (es) | Metodo para producir prasugrel de alta pureza o una sal acida de adicion del mismo | |
AR050518A1 (es) | Proceso de amonolisis para la preparacion de intermedarios para inhibidores de dpp iv | |
EA200702670A1 (ru) | Препарат тиенопиридинового ингибитора агрегации тромбоцитов | |
ATE441630T1 (de) | Substituierte cyclopenten-verbindungen | |
AR048876A1 (es) | Un proceso para preparar montelukast y compuestos intermedios para el mismo | |
EA200701738A1 (ru) | Способ получения транс-1-((1r,3s)-6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазина | |
ATE519737T1 (de) | Organische verbindungen | |
AR057909A1 (es) | Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico. | |
AR109729A1 (es) | Método para producir la forma cristalina de modificación a de calcobutrol | |
PE20060466A1 (es) | Proceso para preparar bisulfato de atazanavir y formas cristalinas del mismo | |
AR064658A1 (es) | Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma | |
AR099594A2 (es) | Proceso para preparar bisulfato de atazanavir y otras formas | |
AR044019A1 (es) | Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas | |
AR049695A1 (es) | Procedimiento para preparar un compuesto tiazol y compuesto intermediario de sintesis | |
EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
EA201071424A1 (ru) | Сульфонатные соли 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина | |
NO20075930L (no) | Fremgangsmate for fremstilling av alkalimetallsalt | |
ATE466003T1 (de) | Herstellung von 2-aminothiazol-5- carbonsäurederivaten | |
NI201000144A (es) | Procedimiento de preparación de combretastatina | |
EA200801960A1 (ru) | Соли дулоксетина |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |